What should personalized, precision treatment of cancer look like in the future?
We know that people are different, their tumors are different, and they respond differently to different therapies. Medical teams of the future might be able to create a ?“virtual twin” of a person and their tumor. Then, by tapping supercomputers, physician-led teams could simulate how tumor cells behave to test millions (or billions) of possible treatment combinations. Ultimately, the best combinations might offer clues towards a personalized, effective treatment plan.
Sound like wishful thinking? The first steps towards this vision have been undertaken by a multi-institution research collaboration that includes Jonathan Ozik and Nicholson Collier, computational scientists at the U.S. Department of Energy’s Argonne National Laboratory.
The research team, which includes collaborators at Indiana University and the University of Vermont Medical Center, brought the power of high-performance computing to the thorny challenge of improving cancer immunotherapy. The team tapped twin supercomputers at Argonne and the University of Chicago, finding that high-performance computing can yield clues in fighting cancer, as discussed in a June 7 article published in Molecular Systems Design and Engineering.
“With this new approach, researchers can use agent-based modeling in more scientifically robust ways.” — Nicholson Collier, computational scientist at Argonne and the University of Chicago
Standing up to cancer
Cancer immunotherapy is a promising treatment that realigns your immune system to reduce or eliminate cancer cells. The therapy, however, helps only 10 to 20 percent of patients — partly because the way in which cancer cells and immune cells mingle is complex and poorly understood. Proven rules are scarce.
To begin uncovering the rules of immunotherapy, the team turned to a set of three tools:
- Agent-based modeling, which predicted the behavior of individual ?“agents” – cancer and immune cells, in this case
- Argonne’s award-winning workflow technology to take full advantage of the supercomputers
- A guiding framework to explore models and dynamically direct and track results
The trio operate in a hierarchy. The framework, developed by Ozik, Collier, Argonne colleagues, and Gary An, a surgeon and professor at the University of Vermont Medical Center, is called Extreme-scale Model Exploration with Swift (EMEWS). It oversees the agent-based model and the workflow system, the Swift/T parallel scripting language, developed at Argonne and the University of Chicago.
What is unique about this combination of tools? ?“We are helping more people in a variety of computational science fields to do large-scale experimentation with their models,” said Ozik, who — like Collier — holds a joint appointment at the University of Chicago. ?“Building a model is fun. But without supercomputers, it is difficult to really understand the full potential of how models can behave.”
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Foundation Medicine Expands Research & Development Operations in San Diegoon October 7, 2020 at 4:38 am
New Foundation Medicine location in San Diego will expand genomic research and testing capacity for the advancement of cancer care ...
- Opening the black box of childhood cancer: Results from Australian personalized medicine programon October 5, 2020 at 8:11 am
The success of an Australian program which aims to find the most-likely-to-succeed personalized treatment recommendations for children with high risk cancer has been revealed in a paper published ...
- Nationwide provider of personalized healthcare acquires South Carolina holistic medical clinicon October 2, 2020 at 8:42 am
Forum Health, LLC, a nationwide provider of personalized functional and integrative medicine, has acquired Wellness by Design, a holistic medical clinic based in Greenville, South Carolina.
- Expert: COVID-19 shows need for individualized medicineon October 1, 2020 at 2:42 pm
The promise of truly personalized medicine has been on the horizon for decades. "When we got to the genome sequencing era at the turn of the century it became apparent that each of us are unique, even ...
- SMART researchers receive Intra-CREATE grant for personalized medicine and cell therapyon October 1, 2020 at 12:05 pm
MIT Alliance for Research and Technology have been awarded Intra-CREATE grants to help support research on retinal biometrics for glaucoma progression and neural cell implantation therapy for spinal ...
- BC Platforms Announces Colorado Center for Personalized Medicine Joins Global Data Partner Network BCRQUEST.comon October 1, 2020 at 6:30 am
CCPM's significant advancements in making pharmacogenomics a standard of care are already providing benefits, and with plans to expand the provision ...
- 'A new frontier in personalized medicine': Canadian study finds gut plays major role in some cancer treatmentson September 29, 2020 at 8:01 am
A new study out of London, Ont. is shedding light on the role your gut, and the bacteria within, may play in the effectiveness of some cancer treatments.
- Personalized Medicine Market Set to Witness Surge in Demand over the Forecast Period of 2017-2025on September 25, 2020 at 9:49 am
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors ...
- Parsing Policy: How One Jurist’s Death Can Upend Health Care; Personalized Medicine, Abortion Rights At Riskon September 25, 2020 at 6:43 am
Ruth Bader Ginsburg’s death last week was undoubtedly a loss for those who loved and admired her. It also may have dealt a devastating blow to the entire U.S. health-care system and nearly every ...
- Personalized medicine is the future of health care. Two Trump administration proposals could stymie iton September 25, 2020 at 2:01 am
An executive order to lower drug prices and an HHS proposal about laboratory tests threaten to derail progress toward personalized medicine.
via Bing News